Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 98 clinical trials
Folic Acid Supplement Versus Placebo for Treating Mucositis Adverse Events in Metastatic Renal Cell Carcinoma Patients Receiving Targeted Therapy

FASTERCC: Folic acid supplement versus placebo for treating mucositis adverse events in metastatic renal cell carcinoma patients receiving targeted therapy. A randomized, double-blind trial from

hysterectomy
cancer
metastatic renal cell carcinoma
  • 7 views
  • 24 Jan, 2021
  • 3 locations
Impact of the PRISM-care Multidisciplinary Oncology Program on Secured Drug Intake of Patients With Kidney Cancer

they involve prescription changes (dose reduction, treatment interruption). This results in a decrease in the dose taken and a risk of loss of efficacy. In the context of metastatic renal cell

cancer
targeted therapy
kidney cancer
tyrosine
pazopanib
  • 63 views
  • 03 Feb, 2021
  • 18 locations
Parametric PET of Renal Cell Carcinoma

Metastatic kidney cancer is usually treated with targeted therapy or immunotherapy which is costly and has low response rate. The current standard care is to perform anatomical imaging studies

hysterectomy
cancer
targeted therapy
kidney cancer
pazopanib
  • 0 views
  • 25 Jan, 2021
  • 1 location
Decitabine Combined With Oxaliplatin in Patients With Advanced Renal Cell Carcinoma

objective of this phase II clinical trial is to investigate the efficacy and safety of sequential combination therapy with decitabine and oxaliplatin in patients with relapsed/metastatic renal cell

oxaliplatin
cancer
platelet count
neutrophil count
myocardial infarction
  • 1 views
  • 23 Jan, 2021
  • 1 location
Radiotherapy as an Immunological Booster in Patients With Metastatic Melanoma or Renal Cell Carcinoma Treated With High-dose Interleukin-2

Title: Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with High-dose Interleukin-2: evaluation of biomarkers of immunologic and therapeutic response Phase: Proof of Principle phase II study Study Design: Single center, open-label trial to assess the immune response and potential biomarkers predictive of …

ct scan
neutrophil count
interleukin 2
ipilimumab
interleukin-2
  • 27 views
  • 04 Mar, 2021
  • 1 location
Probiotic Yogurt Supplement in Reducing Diarrhea in Patients With Metastatic Kidney Cancer Being Treated With Vascular Endothelial Growth Factor-Tyrosine Kinase Inhibitor

This randomized clinical trial studies how well probiotic yogurt supplement works in reducing diarrhea in patients with kidney cancer that has spread from the primary site to other places in the body (metastatic) and that are being treated with vascular endothelial growth factor-tyrosine kinase inhibitor therapy. Studying samples of blood …

growth factor
biomarker analysis
cancer
vascular endothelial growth factor
tyrosine
  • 20 views
  • 27 Jan, 2021
  • 1 location
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer the PROBE Trial

This phase III trial compares the effect of adding surgery to a standard of care immunotherapy-based drug combination versus a standard of care immunotherapy-based drug combination alone in treating patients with kidney cancer that has spread to other places in the body (metastatic). Immunotherapy with monoclonal antibodies, such as nivolumab, …

  • 0 views
  • 05 Mar, 2021
  • 164 locations
INJECT: A Pilot Study of Intra-tumoral Injections in Metastatic Urological Cancers

The purpose of this study is to plan for future clinical trials in patients with metastatic urological cancers. Diluted iodinated contrast will be injected intra-tumorally under CT fluoroscopy guidance into bone, lymph node, soft tissue and liver metastases in subjects with metastatic prostate cancer, urothelial carcinoma, or renal cell carcinoma. …

cancer
liver metastasis
metastasis
  • 0 views
  • 24 Jan, 2021
  • 1 location
Role of PRoactivE Coaching on PAtient REported Outcome in Advanced or Metastatic RCC Treated With Sunitinib

The primary objective of the trial is to determine the effect of a 24-week concomitant coaching on patient reported outcomes of patients receiving standard treatment for mRCC with sunitinib.

hysterectomy
kinase inhibitor
sunitinib
oophorectomy
measurable disease
  • 70 views
  • 24 Jan, 2021
  • 29 locations
Study Assessing Stereotactic Radiotherapy in Therapeutic Strategy of Oligoprogressive Renal Cell Carcinoma Metastases

Every year, 12500 primary renal cell carcinoma (RCC) are diagnosed in France. Metastases occur in half of RCC patients. Management of metastatic RCC is based on systemic treatments (targeted therapies/immunotherapy). However, resistance to systemic treatment is frequent. In case of progression, usual therapeutic attitude is initiating another systemic therapy. Because …

cancer
ct scan
tyrosine
kidney cancer
stereotactic radiation therapy
  • 0 views
  • 24 Jan, 2021
  • 14 locations